Most of us are aware of his life — the vision that changed how we see the digital world today. Through a series of revolutionary products and innovations that reshaped entire industries and society itself, it won’t be an overstatement to say that Apple has now become royalty in the field of technology and its advancement.
Kidney disease among top 10 causes of death; 800 million people affected and most don’t even know it: Here’s how to catch it earlyThe man behind that innovation is Steve Jobs, who started Apple in the garage of his parents' home in 1976. In fact, while the company was founded in the garage, the initial work on the first computer, the Apple I, was completed in Jobs' own bedroom before moving to the garage.
Apple grew quickly enough to move out of the garage, and the rest is history.
Although the world is well-versed with the story of Apple’s ascent and Jobs’ vision behind it, very few know how Jobs succumbed to death.
On October 5, 2011, Jobs died at just 56 from complications of pancreatic cancer. But the form of cancer that claimed his life wasn’t the aggressive “regular” type most people refer to when they hear “pancreatic cancer.” Jobs was diagnosed with a rare neuroendocrine tumor of the pancreas — a different beast entirely. Let's learn more about the condition...
Jobs’ diagnosis: What happened
In October 2003, Steve Jobs was diagnosed with a tumor of the islet cells of the pancreas — a type known as a pancreatic neuroendocrine tumor (pNET), or islet-cell neuroendocrine tumor. He publicly announced the
condition in mid-2004 and later underwent surgery to remove the tumor (a procedure called the Whipple operation or pancreaticoduodenectomy).
Initially, he chose to delay conventional treatment for about nine months, opting for alternative therapies (diet, acupuncture, herbal treatment) before finally consenting to surgery in July 2004.
In 2009, when the disease had progressed to the liver, Jobs underwent a liver transplant. His health continued to deteriorate, and he ultimately died from respiratory arrest caused by complications of his tumor.
It’s noteworthy that the form of pancreatic tumor he had is much less common and far less aggressive than the standard pancreatic adenocarcinoma.
What is a pancreatic neuroendocrine tumor and how it differs from “regular” pancreatic cancer
The most common type of pancreatic cancer (about 95% of cases) is pancreatic adenocarcinoma, which arises from the exocrine part of the pancreas (the part that produces digestive enzymes) — whereas Jobs’ tumor was an endocrine tumor of the islet cells (which make hormones), a pNET.
What are the key differences?When it comes to growth rate and prognosis, pNETs tend to grow more slowly and have better survival rates when caught early. On the other hand, adenocarcinoma is aggressive, often diagnosed late, and has a very poor prognosis. Besides, adenocarcinoma is notoriously silent until advanced. Meanwhile, pNETs may manifest differently and — on the brighter side — sometimes are found much earlier.
Also See:
Pancreas health: 5 symptoms that can help detect pancreatic cancer and pancreatitis earlyEarly signs and risk factors
One major challenge with all pancreatic cancers is that early symptoms are often quite vague and non-specific — think upper abdominal pain, weight loss, loss of appetite, jaundice (yellowing of skin and/or eyes) if the bile ducts are blocked. In the case of neuroendocrine tumors, they may sometimes produce hormone-related symptoms (depending on what hormone the tumor secretes), which come to attention comparatively sooner and hence can be found relatively quickly. Early detection remains difficult, so paying attention to persistent, unexplained symptoms and seeking medical evaluation promptly is the safest approach.
As for risk factors, they differ by the type of pancreatic cancer. While for the regular (adenocarcinoma) type, the known risk factors include smoking, obesity, chronic pancreatitis (perhaps alcohol-related), and family history, for neuroendocrine tumors of the pancreas, the risk factors are much less well-defined. For starters, heredity may play a role in some cases (e.g., in conditions such as Multiple Endocrine Neoplasia type 1 / MEN1), but many instances of pNET occur without obvious risk factors as well.
Mortality and survival rates
Pancreatic adenocarcinoma, by far, is one of the
worst prognoses among cancers. Only around 10-15% are diagnosed when surgery is possible, and the five-year survival is often below 5–6%. For pNETs like Jobs had, the survival outlook is considerably better when it is detected early and receives proper treatment — in fact, surgical removal is more frequently successful if done at an early stage. In Jobs’s case, after his 2003 diagnosis (publicly announced in 2004), he lived until 2011 — he himself survived about eight years, which was longer than typical for pancreatic cancers.
Some feasible treatment options for pNETs include surgery, chemotherapy, targeted therapy, somatostatin analogs, and locoregional therapies like PRRT. Although surgery is the only potentially curative option, other treatments are often used for advanced or unresectable disease to control symptoms, slow tumor growth, and extend survival. However, the specific approach depends on the tumor's characteristics, such as its stage, location, and functionality. And it's important to remember that even for pNETs, once metastasis (such as to the liver) occurs, the disease becomes much harder to treat.
How to manage pNETs?
There is no sure or known way to prevent all pNETs because many risk factors, such as family history and genetics, are uncontrollable. However, for Pancreatic Neuroendocrine Tumors, specifically, certain lifestyle changes may help lower the risk.
For starters, smoking is an avoidable risk factor, and quitting may help reduce your risk. Heavy alcohol consumption, too, can lead to chronic pancreatitis, a condition that increases the risk of pNETs. Reducing alcohol intake may help lower this risk. Additionally, it's important to maintain a healthy weight, as obesity is a risk factor for various cancers, including pancreatic cancer, and maintaining a healthy weight through diet and exercise may help reduce risk. Regular health checkups and timely management of underlying conditions, such as diabetes or chronic pancreatitis, can also support early detection and potentially reduce complications related to pNETs. Raising awareness about the subtle symptoms and differences between pancreatic cancer types can encourage earlier diagnosis and potentially save lives through timely medical intervention.
Ultimately, staying informed and proactive about one’s health can make a significant difference, as early detection and timely treatment remain the strongest tools in improving outcomes for pancreatic neuroendocrine tumors.
Get an chance to win ₹5000 Amazon Voucher by taking part in India's Biggest Habit Index! Take the survey here